JSAM
J. Safra Asset Management Portfolio holdings
AUM
$1.38B
1-Year Return
16.76%
This Quarter Return
+5.53%
1 Year Return
+16.76%
3 Year Return
+74.03%
5 Year Return
+124.37%
10 Year Return
–
AUM
$1.05B
AUM Growth
+$61.3M
(+6.2%)
Cap. Flow
+$17.7M
Cap. Flow
% of AUM
1.68%
Top 10 Holdings %
Top 10 Hldgs %
75.78%
Holding
322
New
54
Increased
182
Reduced
11
Closed
24
Top Buys
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
$38.4M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$33.9M |
| 3 |
SPDR Gold Trust
GLD
|
$6.97M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$4.78M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
$4.14M |
Top Sells
| 1 |
VanEck Semiconductor ETF
SMH
|
$30.5M |
| 2 |
Invesco QQQ Trust
QQQ
|
$24.7M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
$23.5M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
$6.6M |
| 5 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
$2.65M |
Sector Composition
| 1 | Technology | 1.16% |
| 2 | Consumer Discretionary | 0.55% |
| 3 | Financials | 0.43% |
| 4 | Communication Services | 0.39% |
| 5 | Healthcare | 0.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
American Eagle Outfitters
AEO
$3.18B
| $8.7K | ﹤0.01% |
396
+352
| +800% | +$7.73K |
|
252
Univest Financial
UVSP
$897M
| $8.63K | ﹤0.01% |
317
+282
| +806% | +$7.68K |
|
253
Northern Oil and Gas
NOG
$2.41B
| $8.37K | ﹤0.01% |
238
+212
| +815% | +$7.46K |
|
254
Valaris
VAL
$3.63B
| $8.35K | ﹤0.01% |
149
+133
| +831% | +$7.46K |
|
255
Caleres
CAL
$528M
| $7.28K | ﹤0.01% |
+218
| New | +$7.28K |
|
256
Celldex Therapeutics
CLDX
$1.52B
| $6.08K | ﹤0.01% |
183
+158
| +632% | +$5.25K |
|
|
PENG
257
Penguin Solutions, Inc. Ordinary Shares
PENG
$1.3B
| $6.01K | ﹤0.01% |
282
+242
| +605% | +$5.16K |
|
258
Rocky Brands
RCKY
$218M
| $5.88K | ﹤0.01% |
185
+159
| +612% | +$5.05K |
|
259
Diodes
DIOD
$2.48B
| $5.85K | ﹤0.01% |
92
+79
| +608% | +$5.03K |
|
260
Bankunited
BKU
$2.92B
| $5.16K | ﹤0.01% |
145
+124
| +590% | +$4.41K |
|
261
Advance Auto Parts
AAP
$3.59B
| $4.97K | ﹤0.01% |
120
+103
| +606% | +$4.26K |
|
262
First Northwest Bancorp
FNWB
$63.5M
| $3.77K | ﹤0.01% |
351
+301
| +602% | +$3.23K |
|
263
Regeneron Pharmaceuticals
REGN
$60.4B
| $3.13K | ﹤0.01% |
+3
| New | +$3.13K |
|
264
Penumbra
PEN
$11B
| $2.49K | ﹤0.01% |
+13
| New | +$2.49K |
|
265
Insulet
PODD
$24.4B
| $2.09K | ﹤0.01% |
+9
| New | +$2.09K |
|
266
Arvinas
ARVN
$587M
| $1.98K | ﹤0.01% |
80
+68
| +567% | +$1.68K |
|
267
Alnylam Pharmaceuticals
ALNY
$59.5B
| $1.92K | ﹤0.01% |
+7
| New | +$1.92K |
|
268
Stryker
SYK
$149B
| $1.44K | ﹤0.01% |
+4
| New | +$1.44K |
|
269
Legend Biotech
LEGN
$6.6B
| $1.38K | ﹤0.01% |
+28
| New | +$1.38K |
|
270
Exact Sciences
EXAS
$10.2B
| $1.25K | ﹤0.01% |
+19
| New | +$1.25K |
|
271
Inspire Medical Systems
INSP
$2.57B
| $1.22K | ﹤0.01% |
+6
| New | +$1.22K |
|
272
Masimo
MASI
$7.95B
| $1.2K | ﹤0.01% |
+9
| New | +$1.2K |
|
273
Surgery Partners
SGRY
$2.88B
| $1.15K | ﹤0.01% |
+36
| New | +$1.15K |
|
274
Glaukos
GKOS
$5.37B
| $1.03K | ﹤0.01% |
+8
| New | +$1.03K |
|
275
CVS Health
CVS
$93.3B
| $921 | ﹤0.01% |
+15
| New | +$921 |
|